Literature DB >> 19306358

Microglia and neuropathic pain.

Kazuhide Inoue1, Makoto Tsuda.   

Abstract

In contrast to physiological pain, pathological pain is not dependent on the presence of tissue-damaging stimuli. One type of pathological pain--neuropathic pain--is often a consequence of nerve injury or of diseases such as diabetes, AIDS, or cancer. Neuropathic pain can be agonizing, can persist over long periods, and, unfortunately, is often resistant to known painkillers. There is a rapidly growing body of evidence indicating that microglia, the CNS immune cells, have causal roles in the pathogenesis of pain hypersensitivity following nerve injury. We will review recent advances in our understanding of the mechanisms producing neuropathic pain, focusing on the roles of microglia-expressed molecules, including cell surface receptors, intracellular signaling molecules, and diffusible factors involved in nerve injury-induced pain behaviors and hyperexcitability of dorsal horn neurons. Elucidating how spinal microglia cause neuropathic pain may provide us with exciting insights into pain mechanisms and clues for developing new drugs for the treatment of neuropathic pain. (c) 2009 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2009        PMID: 19306358     DOI: 10.1002/glia.20871

Source DB:  PubMed          Journal:  Glia        ISSN: 0894-1491            Impact factor:   7.452


  114 in total

1.  CCL2 promotes P2X4 receptor trafficking to the cell surface of microglia.

Authors:  Emika Toyomitsu; Makoto Tsuda; Tomohiro Yamashita; Hidetoshi Tozaki-Saitoh; Yoshitaka Tanaka; Kazuhide Inoue
Journal:  Purinergic Signal       Date:  2012-01-06       Impact factor: 3.765

2.  ATP-P2X7 receptor signaling controls basal and TNFα-stimulated glial cell proliferation.

Authors:  Jian Zou; Ryan P Vetreno; Fulton T Crews
Journal:  Glia       Date:  2012-02-01       Impact factor: 7.452

Review 3.  Role of astrocytes in pain.

Authors:  C-Y Chiang; B J Sessle; J O Dostrovsky
Journal:  Neurochem Res       Date:  2012-05-26       Impact factor: 3.996

4.  Spinal injection of TNF-α-activated astrocytes produces persistent pain symptom mechanical allodynia by releasing monocyte chemoattractant protein-1.

Authors:  Yong-Jing Gao; Ling Zhang; Ru-Rong Ji
Journal:  Glia       Date:  2010-11-15       Impact factor: 7.452

5.  Neuropathic pain and neuron-glia interactions in the spinal cord.

Authors:  Tatsuro Kohno
Journal:  J Anesth       Date:  2010-03-18       Impact factor: 2.078

Review 6.  Chemokines, neuronal-glial interactions, and central processing of neuropathic pain.

Authors:  Yong-Jing Gao; Ru-Rong Ji
Journal:  Pharmacol Ther       Date:  2010-02-01       Impact factor: 12.310

7.  Spinal inhibition of p38 MAP kinase reduces inflammatory and neuropathic pain in male but not female mice: Sex-dependent microglial signaling in the spinal cord.

Authors:  Sarah Taves; Temugin Berta; Da-Lu Liu; Sophie Gan; Gang Chen; Yong Ho Kim; Thomas Van de Ven; Stefan Laufer; Ru-Rong Ji
Journal:  Brain Behav Immun       Date:  2015-10-19       Impact factor: 7.217

Review 8.  Toll-like receptors in chronic pain.

Authors:  Lauren Nicotra; Lisa C Loram; Linda R Watkins; Mark R Hutchinson
Journal:  Exp Neurol       Date:  2011-10-06       Impact factor: 5.330

Review 9.  Microglial phenotype and adaptation.

Authors:  B J L Eggen; D Raj; U-K Hanisch; H W G M Boddeke
Journal:  J Neuroimmune Pharmacol       Date:  2013-07-25       Impact factor: 4.147

10.  Alleviation of chronic pain following rat spinal cord compression injury with multimodal actions of huperzine A.

Authors:  Dou Yu; Devang K Thakor; Inbo Han; Alexander E Ropper; Hariprakash Haragopal; Richard L Sidman; Ross Zafonte; Steven C Schachter; Yang D Teng
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-05       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.